SciTransfer
Organization

DEMCON BUNOVA B.V.

Dutch engineering firm providing software, testing and compliance infrastructure for advanced semiconductor manufacturing and medical device regulation.

Engineering firmdigitalNLNo active H2020 projects
H2020 projects
3
As coordinator
0
Total EC funding
Unique partners
78
What they do

Their core work

DEMCON BUNOVA is a Dutch engineering and software firm based in Enschede, part of the wider DEMCON high-tech systems group. Their work sits at the intersection of industrial software, system engineering, and regulated product development — from semiconductor equipment control software to compliance tooling for medical devices. They are the kind of partner consortia bring in when a research prototype needs to survive contact with industrial reality: measurement, software integration, testing frameworks, and regulatory readiness.

Core expertise

What they specialise in

Semiconductor equipment and process softwareprimary
2 projects

Contributor to SeNaTe (7nm node technology) and TAPES3 (3nm semiconductor pilot line), both large ECSEL/IA industrial pilot programmes.

Medical device regulatory compliance and testing infrastructureemerging
1 project

Third-party role in MDOT (Medical Device Obligations Taskforce), focused on MDR testing databases, biocompatibility and device safety networks.

Industrial software and data infrastructuresecondary
2 projects

Combined TAPES3 (materials/process data for advanced nodes) and MDOT (regulatory database, blockchain traceability) show recurring work on structured data platforms for regulated industries.

High-tech systems integrationsecondary
3 projects

All three projects are large multi-partner IAs where BUNOVA plays the integration specialist connecting hardware/process partners with software and compliance workflows.

Evolution & trajectory

How they've shifted over time

Early focus
Advanced semiconductor nodes
Recent focus
Medical device regulatory software

In 2015-2018 their H2020 footprint was purely semiconductor: SeNaTe (7nm) and the follow-on TAPES3 (3nm) placed them inside Europe's advanced-node manufacturing push, working on process, equipment and materials software. From 2019 onward the profile broadens sharply into medical device regulation via MDOT — MDR compliance, biocompatibility testing databases, and blockchain-based device traceability. The shift suggests a deliberate move from pure semiconductor tooling into regulated-industry software platforms where the underlying skills (data systems, testing, compliance) transfer well.

Heading toward regulated-industry software platforms — MDR compliance, traceability, and testing databases — while retaining a foothold in semiconductor process tooling.

Collaboration profile

How they like to work

Role: third_party_expertReach: European15 countries collaborated

They consistently appear as a third-party contributor rather than coordinator or formal beneficiary, joining large industrial Innovation Actions alongside 78 different partners across 15 countries. This pattern points to a specialist subcontractor role: brought in by a prime beneficiary for a defined software or testing contribution, not to lead work packages. They are easy to plug into an existing consortium for a bounded technical deliverable.

A broad European network of 78 distinct partners across 15 countries, built through participation in two ECSEL semiconductor flagships and one medical device consortium. The geographic spread reflects the pan-European nature of those flagships rather than a targeted partnering strategy.

Why partner with them

What sets them apart

Most Dutch software firms in H2020 sit in one vertical; BUNOVA bridges two very different regulated worlds — sub-10nm semiconductor manufacturing and MDR-regulated medical devices. That cross-domain software and compliance experience is rare. For a consortium that needs an integrator who already understands both equipment-side data pipelines and regulated product documentation, they are an unusually well-matched partner.

Notable projects

Highlights from their portfolio

  • TAPES3
    Major ECSEL-IA pilot line for 3nm semiconductor technology — one of Europe's most strategic advanced-manufacturing programmes.
  • MDOT
    Marks their pivot from semiconductors into medical device regulation, combining MDR, biocompatibility testing and blockchain traceability in one project.
  • SeNaTe
    Their entry point into H2020, on 7nm node technology, establishing the semiconductor track record that led into TAPES3.
Cross-sector capabilities
healthmanufacturingmultidisciplinary
Analysis note: Only three projects and all as third party, with no EC funding figures recorded. Expertise areas are inferred from project titles and keywords rather than detailed role data; the semiconductor-to-medical-device pivot is the clearest signal and is well-supported, but finer claims about specific technical deliverables should be verified with the organization directly.